Avadel Pharmaceuticals
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell AVDL and other ETFs, options, and stocks.About AVDL
Avadel Pharmaceuticals Plc engages in the development and commercialization of pharmaceutical products. Its main product is LUMRYZ is an extended-release formulation of sodium oxybate, which used in the treatment of cataplexy or EDS in adults with narcolepsy.
CEOGregory J. Divis
CEOGregory J. Divis
Employees188
Employees188
HeadquartersDublin, Dublin
HeadquartersDublin, Dublin
Founded2015
Founded2015
Employees188
Employees188
AVDL Key Statistics
Market cap2.10B
Market cap2.10B
Price-Earnings ratio-3,894.55
Price-Earnings ratio-3,894.55
Dividend yield—
Dividend yield—
Average volume1.55M
Average volume1.55M
High today$21.46
High today$21.46
Low today$21.38
Low today$21.38
Open price$21.42
Open price$21.42
Volume1.39M
Volume1.39M
52 Week high$23.57
52 Week high$23.57
52 Week low$6.38
52 Week low$6.38
Stock Snapshot
With a market cap of 2.1B, Avadel Pharmaceuticals(AVDL) trades at $21.45. The stock has a price-to-earnings ratio of -3894.55.
On 2025-12-19, Avadel Pharmaceuticals(AVDL) stock moved within a range of $21.38 to $21.46. With shares now at $21.45, the stock is trading +0.3% above its intraday low and -0.0% below the session's peak.
Trading activity shows a volume of 1.39M, compared to an average daily volume of 1.55M.
The stock's 52-week range extends from a low of $6.38 to a high of $23.57.
The stock's 52-week range extends from a low of $6.38 to a high of $23.57.
Analyst ratings
91%
of 11 ratingsBuy
0%
Hold
90.9%
Sell
9.1%
People also own
Based on the portfolios of people who own AVDL. This list is generated using Robinhood data, and it’s not a recommendation.